A fusion peptide directs enhanced systemic dystrophin exon skipping and functional restoration in dystrophin-deficient mdx mice.
Duchenne muscular dystrophy (DMD) is caused by mutations in the DMD gene that abolish the synthesis of dystrophin protein. Antisense oligonucleotides (AOs) targeted to trigger excision of an exon bearing a mutant premature stop codon in the DMD transcript have been shown to skip the mutated exon and...
主要な著者: | Yin, H, Moulton, H, Betts, C, Seow, Y, Boutilier, J, Iverson, P, Wood, M |
---|---|
フォーマット: | Journal article |
言語: | English |
出版事項: |
2009
|
類似資料
-
Functional rescue of dystrophin-deficient mdx mice by a chimeric peptide-PMO
著者:: Yin, H, 等
出版事項: (2010) -
Hexose enhances oligonucleotide delivery and exon skipping in dystrophin-deficient mdx mice
著者:: Gang Han, 等
出版事項: (2016-03-01) -
Good news for the mdx mouse community: Improved dystrophin restoration after skipping mouse dystrophin exon 23
著者:: Annemieke Aartsma-Rus
出版事項: (2022-12-01) -
Context dependent effects of chimeric peptide morpholino conjugates contribute to dystrophin exon-skipping efficiency
著者:: Yin, HF, 等
出版事項: (2016) -
Cmah-dystrophin deficient mdx mice display an accelerated cardiac phenotype that is improved following peptide-PMO exon skipping treatment
著者:: Betts, C, 等
出版事項: (2018)